Intravenously administered interleukin-7 to reverse lymphopenia in patients with septic shock: a double-blind, randomized, placebo-controlled trial
Thomas Daix, Bruno François(Inserm), Michel Morre, Andrew H. Walton(Washington University in St. Louis), Jacqueline Unsinger(Washington University in St. Louis), Frederique Berbille, Teresa Blood(Washington University in St. Louis), Robin Jeannet(Hôpital Universitaire Dupuytren), Lyle L. Moldawer(University of Florida), Jean‐Paul Mira(Hôpital Cochin), Pierre‐François Dequin(Université de Tours), Scott C. Brakenridge(University of Florida), Richard S. Hotchkiss(Washington University in St. Louis), Armelle Mathonnet(Centre Hospitalier Universitaire d'Angers), Jane Blood(Washington University in St. Louis)
Cited by 76
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Genomic responses in mouse models poorly mimic human inflammatory diseases
|Proceedings of the National Academy of Sciences|2013|3k
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
|New England Journal of Medicine|2015|2.4k
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
|JAMA|2020|2.4k
Sepsis and septic shock
|Nature Reviews Disease Primers|2016|1.6k